Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,191.00
-18.00 (-1.49%)
At close: Mar 9, 2026
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 2.65 billion as of March 9, 2026. Its market cap has decreased by -48.09% in one year.
Market Cap
2.65B
Enterprise Value
3.69B
Revenue
2.49B
Ranking
n/a
PE Ratio
8.99
Stock Price
1,191.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 2.65B, an increase of 464.68%. That is a compound annual growth rate of 8.88%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 1.84B |
| Allergy Therapeutics | 728.24M |
| Haleon | 33.58B |
| Animalcare Group | 189.19M |
| Shield Therapeutics | 95.09M |
| Venture Life Group | 82.49M |
| ECO Animal Health Group | 62.68M |
| Provexis | 29.32M |